Comparison of the effects of fish oil containing multicomponent and standard lipid emulsion on parenteral nutrition associated cholestasis.

Yıl 2015, Cilt: 46 Sayı: 1, 22 - 27, 21.01.2015

Halil Değirmencioğlu , Mehmet Öncel , Erhan Çalışıcı Yavuz Yılmaz Şerife Suna Oğuz Uğur Dilmen

https://doi.org/10.16948/zktb.67240

Öz

Objective: To compare the effect of a multicomponent parenteral lipid emulsion (PLE) with a standard PLE in case of cholestasis induced by long-term use of parenteral nutrition (PN) in infants who need surgical procedures.

Material and Method: We conducted a retrospective study in neonatal intensive care unit (NICU) between January 2011 and February 2012. The patients with surgical procedures and need for long-term PN (at least 2 weeks) at NICU were enrolled in the study. Group 1: given standard lipid emulsion, in addition to the standard treatment of cholestasis, Group 2: given multicomponent lipid emulsion (soybean oil, medium chain triglyceride, olive and lipid fish oil) in addition to the standard treatment of cholestasis. Period of cholestasis and prognosis data were compared during follow-up in NICU.

Results: A total of 24 patients (Group 1 (n = 11) and Group 2 (n = 13)) were included in the study. Period of cholestasis were similar between groups. Despite the inequality between gestational age and birthweight among groups (gestational age 36±4.3 and 30.3±3.4 weeks and p=0,047, birth weight mean 2395±635 and 1404 ±670 g, p=0.03 , respectively Group 1 and 2), total non-feeding time (Group 1: 10 ± 3.3 days; Group 2: 16.3 ± 10.6 days) and total duration of PN (group 1: 20 ± 4.6 days; Group 2: 25.8 ± 17 days) and mortality rates were compared between the groups and there was no statistically difference. There were no short-term adverse effects identified due to the use of multi-component PLE.

Conclusion: No additional contribution of multicomponent PLE than standard PLE to the treatment of cholestasis could be shown at our study. We think that inequality among groups may effect these results.

Anahtar Kelimeler

Parenteral nutrition, cholestasis, surgical case, multi component lipid emulsion

Balık yağı içeren çok bileşenli ile standart lipid emülsiyonlarının parenteral nutrisyon ilişkili kolestaz üzerine etkilerinin karşılaştırılması.

Öz

Amaç: Yenidoğan döneminde özellikle cerrahi işlem ihtiyacı duyan, uzun süre parenteral beslenme (PB) kullanımına bağlı kolestaz gelişen olgularda standart tedaviye ek olarak verilen balık yağı içeren çok bileşenli ile standart lipid emülsiyonlarının (PLE) etkisini karşılaştırmak.

Gereç ve Yöntem: Bu retrospektif çalışmaya yenidoğan yoğun bakım ünitesinde (YDYBÜ) Ocak 2011 – Şubat 2012 döneminde yatan,  cerrahi operasyon geçirip 2 haftada ve daha uzun süreli PB ihtiyacı olup PB ilişkili kolestaz gelişen hastalar çalışmaya alındı. Hastalar Grup1, kolestazı olup standart kolestaz tedavisine ek olarak standart PLE (saf soya yağı içeren) verilen, Grup 2  ise ek olarak soya yağı, orta zincirli yağ asidi, zeytin ve balık yağı içeren çok bileşenli PLE verilen olmak üzere iki gruba ayrıldı. Hastaların YYBÜ’de izleminde kolestaz süreleri ve prognozları ile ilgili verileri karşılaştırıldı.

Bulgular: Bu çalışmaya Grup 1 (n= 11) ve Grup 2 (n= 13)’de toplam 24 hasta dâhil edildi. Grup 1 ve 2 için ortalama gestasyonel yaşlar sırasıyla 36±4.3 ve 30.3±3.4 hafta, doğum ağırlıkları ortalama 2395±635 ve 1404 ±670 g idi. Doğum haftaları ve doğum ağırlığı arasında önemli istatistiksel farklılık vardı (sırasıyla p=0.047, p=0.03). Grupların gebelik haftası ve doğum ağırlıkları farklı olmasına rağmen, toplam beslenmeme süresi (Grup 1: 10±3.3 gün; Grup 2: 16.3±10.6 gün) ve total PB süreleri  (Grup 1: 20±4.6 gün; Grup 2: 25.8±17 gün) ve mortalite oranları karşılaştırıldığında gruplar arasında önemli farklılık saptanmadı. Çok bileşenli PLE kullanımına bağlı kısa dönemde yan etki saptanmadı.

Sonuç: Yapılan retrospektif çalışmada değerlendirmeye alınan hastaların demografik verileri arasında fark olmasına rağmen parenteral beslenme ilişkili kolestaz açısından daha riskli olan prematüre bebeklerin sonuçları term bebekler ile benzerdi. Bununla birlikte iki grup  arasında balık yağı içeren çok bileşenli PLE’nin kolestaz ilaç tedavisine ek olarak kullanılmasının, standart PLE kullanılmasına göre ek katkı sağlamadığı gösterildi.  Gruplar arasındaki farkların bu sonucu etkileyebileceğini düşünmekteyiz.

Anahtar Kelimeler

Parenteral beslenme, kolestaz, cerrahi vaka, çok bileşenli lipid emülsiyonu

Kaynakça

• Vlaardingerbroek H, Veldhorst MA, Spronk S, van den Akker CH, van Goudoever JB. Parenteral lipid administration to very-low-birth-weight infants early introduction of lipids and use of new lipid emulsions: a systematic review and metaanalysis. Am J Clin Nutr. 2012 ;96(2):255-268.
• Vlaardingerbroek H, Vermeulen MJ, Carnielli VP, Vaz FM, van den Akker CH, van Goudoever JB.Growth and Fatty Acid Profiles of VLBW Infants Receiving a Multicomponent Lipid Emulsion From Birth. J Pediatr Gastroenterol Nutr. 2014 ;58(4):417-27.
• Wanten GJ. Parenteral lipids in nutritional support and immune modulation. Clin Nutr Suppl 2009;4:13–17.
• Krohn K, Koletzko B. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care 2006;9:319–323.
• Saugstad OD. Oxidative stress in the newborn—a 30-year perspective. Biol Neonate 2005;88:228–236.
• Adolph M. Lipid emulsions in parenteral nutrition. Ann Nutr Metab 1999;43:1–13.
• Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 2006;45:55–60.
• Diamond IR, de Silva NT, Tomlinson GA, et al. The role of parenteral lipids in the development of advanced intestinal-failure associated liver disease in infants: a multiple-variable analysis. J Parenter Enteral Nutr 2011;35:596-602.
• Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000;24:345-50.
• Le HD, de Meijer VE, Zurakowski D, et al. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition associated liver disease. JPEN J Parenter Enteral Nutr 2010; 34:477–484.
• Heller AR, Rössler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34(4):972-9.
• Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008;121(3):e678-86.
• Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int. 2008 ;24(7):773-8.
• Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009;250(3):395-402.
• Chang MI, Puder M, Gura KM.The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients. 2012;4(12):1828-50.
• Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998 ;14(1):158-64.
• Alwayn IP, Andersson C, Zauscher B, Gura K, Nosé V, Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.. Transplantation. 2005 15;79(5):606-8.
• Klein CJ, Revenis M, Kusenda C, Scavo L. Parenteral nutrition-associated conjugated hyperbilirubinemia in hospitalized infants. J Am Diet Assoc. 2010;110(11):1684-95.
• Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R; Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41 Suppl 2:S1-87.
• Willis TC, Carter BA, Rogers SP, et al. High rates of mortality and morbidity occur in infants with parenteral nutrition–associated cholestasis. JPEN J Parenter Enteral Nutr 2010;34(1):32-7.
• Teitelbaum DH, Drongowski R, Spivak D. Rapid development of hyperbilirubinemia in infants with the short bowel syndrome as correlate to mortality: possible indication for early small bowel transplantation. Transplant Proc 1996;28(5):2699-700.
• Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118:e197–201.
• Demirel G, Oguz SS, Celik IH, Erdeve O, Uras N, Dilmen U. The metabolic effects of two different lipid emulsions used in parenterally fed premature infants--a randomized comparative study. Early Hum Dev. 2012;88:499-501.